CICC Research Adjusts Price Target on Edwards Lifesciences to $80 From $105, Maintains Outperform Rating
CICC Research Adjusts Price Target on Edwards Lifesciences to $80 From $105, Maintains Outperform Rating
中金公司研究將愛德華生命科學公司的目標股價從105美元下調至80美元,仍維持跑贏大盤的評級。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊